Sugi Predict

Sugi Predict / Compounds / SCHEMBL4521344

SCHEMBL4521344

SCHEMBL4521344

CCC(=O)N1CCN(c2ccc(C)c(C(=O)N3CC[C@@]4(C3)OC(=O)c3ccccc34)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 2/20 0.48
▸ HSD11B1 P28845 9/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ AVPR1A P37288 2/20 0.42
▸ HRH3 Q9Y5N1 1/20 0.40
▸ NPY5R Q15761 3/20 0.40
▸ TSHR P16473 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4525674 0.93 PDK2 (0.48) PDK2HSD11B1CYP2D6AVPR1AHRH3
SCHEMBL4517418 0.90 PDK2 (0.51) PDK2HSD11B1CYP2D6AVPR1ANPY5R
SCHEMBL4517416 0.90 PDK2 (0.51) PDK2HSD11B1CYP2D6AVPR1ANPY5R
SCHEMBL4519636 0.90 HSD11B1 (0.46) PDK2HSD11B1CYP2D6AVPR1AHRH3
SCHEMBL4501724 0.90 HSD11B1 (0.46) HSD11B1CYP2D6AVPR1AHRH3NPY5R
SCHEMBL4501727 0.90 HSD11B1 (0.46) HSD11B1CYP2D6AVPR1AHRH3NPY5R
SCHEMBL4519969 0.89 HSD11B1 (0.47) PDK2HSD11B1CYP2D6AVPR1AHRH3
SCHEMBL4522738 0.89 HSD11B1 (0.43) HSD11B1CYP2D6AVPR1AHRH3NPY5R
SCHEMBL4525663 0.89 HSD11B1 (0.43) HSD11B1CYP2D6AVPR1ANPY5R
SCHEMBL4526269 0.88 PDK2 (0.48) PDK2HSD11B1CYP2D6AVPR1ANPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298808-A1 INHIBITORS OF 11-BETA HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME INCYTE CORPORATION, A DELAWARE CORPORATION 2009-12-03 — — US claimed
US-20060122210-A1 Inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same INCYTE CORPORATION 2006-06-08 — — US claimed
US-20090298808-A1 INHIBITORS OF 11-BETA HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME INCYTE CORPORATION, A DELAWARE CORPORATION 2009-12-03 — — US disclosed
US-20090298808-A1 INHIBITORS OF 11-BETA HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME INCYTE CORPORATION, A DELAWARE CORPORATION 2009-12-03 — — US disclosed
US-20090298808-A1 INHIBITORS OF 11-BETA HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME INCYTE CORPORATION, A DELAWARE CORPORATION 2009-12-03 — — US disclosed
US-20060122210-A1 Inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same INCYTE CORPORATION 2006-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122210-A1 Inhibitors of 11-beta hydroxyl steroid dehydrogenase type I and methods of using the same HSD11B1, HSD11B2, HSD17B1 PDK2 609/4885HSD11B1 1/4885CYP2D6 253/4885
US-20090298808-A1 INHIBITORS OF 11-BETA HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME HSD11B1, HSD11B2, HSD17B1 PDK2 609/4885HSD11B1 1/4885CYP2D6 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.